Peter Ordentlich

Insider Reports History

Entity
Individual
Location
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 140, Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Ordentlich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Scientific Officer Common Stock 0 $18.27 Feb 15, 2023 Direct
Syndax Pharmaceuticals Inc Chief Scientific Officer Stock Options (Right to buy) 0 $25.84 Feb 15, 2023 Direct

Insider Reports Filed by Peter Ordentlich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc Feb 15, 2023 6 -$1.12M 4 Feb 17, 2023 Chief Scientific Officer
SNDX Syndax Pharmaceuticals Inc Jan 31, 2023 3 $2.57M 4 Feb 3, 2023 Chief Scientific Officer
SNDX Syndax Pharmaceuticals Inc Dec 1, 2022 9 -$467K 4 Dec 2, 2022 Chief Scientific Officer
SNDX Syndax Pharmaceuticals Inc Jul 29, 2022 7 -$464K 4 Aug 26, 2022 Chief Scientific Officer
SNDX Syndax Pharmaceuticals Inc Feb 1, 2022 3 $1.26M 4 Feb 3, 2022 Chief Scientific Officer